Lise Lotte Gluud

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Hepatic Encephalopathy 83%
3. Systematic Reviews 72%
4. Fibrosis 71%
5. Type 2 Diabetes Mellitus 48%
6. Randomized Controlled Trials 36%
7. Confidence Intervals 34%
8. Non-alcoholic Fatty Liver Disease 33%
9. Placebos 30%
10. Odds Ratio 29%
11. Acute Necrotizing Pancreatitis 27%
12. Rifaximin 26%
13. Mortality 25%
14. Branched Chain Amino Acids 23%
15. Glucose 23%
16. Esophageal and Gastric Varices 20%
17. Ribavirin 17%
18. Lactulose 17%
19. Liver Diseases 16%
20. Hepatorenal Syndrome 16%
21. Chronic Hepatitis C 16%
22. Liver 16%
23. Glucagon-Like Peptide-1 Receptor 15%
24. Alcoholic Hepatitis 15%
25. Therapeutics 15%
26. Pancreatitis 15%
27. Sodium-Glucose Transporter 2 Inhibitors 15%